Abstract:Epilepsy is a complex and multifaceted neurological disorder characterized by spontaneous and recurring seizures. It poses significant therapeutic challenges due to its diverse etiology and often-refractory nature. This comprehensive review highlights the pivotal role of AMP-activated protein kinase (AMPK), a key metabolic regulator involved in cellular energy homeostasis, which may be a promising therapeutic target for epilepsy. Current therapeutic strategies such as antiseizure medication (ASMs) can alleviate seizures (up to 70%). However, 30% of epileptic patients may develop refractory epilepsy. Due to the complicated nature of refractory epilepsy, other treatment options such as ketogenic dieting, adjunctive therapy, and in limited cases, surgical interventions are employed. These therapy options are only suitable for a select group of patients and have limitations of their own. Current treatment options for epilepsy need to be improved. Emerging evidence underscores a potential association between impaired AMPK functionality in the brain and the onset of epilepsy, prompting an in-depth examination of AMPK’s influence on neural excitability and ion channel regulation, both critical factors implicated in epileptic seizures. AMPK activation through agents such as metformin has shown promising antiepileptic effects in various preclinical and clinical settings. These effects are primarily mediated through the inhibition of the mTOR signaling pathway, activation of the AMPK-PI3K-c-Jun pathway, and stimulation of the PGC-1α pathway. Despite the potential of AMPK-targeted therapies, several aspects warrant further exploration, including the detailed mechanisms of AMPK’s role in different brain regions, the impact of AMPK under various conditional circumstances such as neural injury and zinc toxicity, the long-term safety and efficacy of chronic metformin use in epilepsy treatment, and the potential benefits of combination therapy involving AMPK activators. Moreover, the efficacy of AMPK activators in refractory epilepsy remains an open question. This review sets the stage for further research with the aim of enhancing our understanding of the role of AMPK in epilepsy, potentially leading to the development of more effective, AMPK-targeted therapeutic strategies for this challenging and debilitating disorder.

AMPK-mediated regulation of neuronal metabolism and function in brain diseases

Highlighting the protective or degenerative role of AMPK activators in dementia experimental models.

AMPK and Diseases: State of the Art Regulation by AMPK-Targeting Molecules

Dissecting the Role of AMP-activated Protein Kinase in Human Diseases

AMPK inhibition in health and disease

AMPK, Mitochondrial Function, and Cardiovascular Disease

AMPK Regulation of Glucose, Lipid and Protein Metabolism: Mechanisms and Nutritional Significance.

AMPK As A Target in Rare Diseases

AMPK: The energy sensor at the crossroads of aging and cancer

AMPK signalling in health and disease

Role of the AMPK pathway in promoting autophagic flux via modulating mitochondrial dynamics in neurodegenerative diseases: Insight into prion diseases

Targeting AMPK for cancer prevention and treatment.

AMPK and its Activator Berberine in the Treatment of Neurodegenerative Diseases

New insights into activation and function of the AMPK

AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome

AMPK as a Therapeutic Target for Treating Metabolic Diseases

AMPK role in epilepsy: a promising therapeutic target?

The regulation effect of AMPK in immune related diseases